Bemis vs. Amcor: What the 2019 Acquisition Actually Means for Your Packaging Budget

Here's the thing about the Bemis-Amcor acquisition: most packaging buyers ask the wrong question.

They ask, "Is Bemis still independent?" or "Did Amcor absorb them completely?" Neither question helps you when you're sitting down with a $180,000 annual packaging budget and trying to decide who gets your business.

The real question — the one nobody's asking — is how does this change my total cost of ownership?

I've been managing procurement for a mid-size food processing company for about six years now. We spend roughly $180,000 annually on flexible packaging across films, pouches, and barrier materials. When Amcor announced the Bemis acquisition back in 2019, I did what any cost controller would do: I started a spreadsheet. Three vendors, side-by-side quotes, TCO calculations, the whole thing.

Let me walk you through what I found, because the answer isn't the same for everyone.

Three Scenarios, Three Different Answers

The Bemis-Amcor merger doesn't affect every buyer the same way. Your situation depends on three factors: your volume, your regulatory requirements (especially in healthcare or food), and whether you value supplier consolidation or redundancy.

Here are the three common scenarios I see:

• Scenario A: You're a high-volume food manufacturer already working with multiple Amcor divisions.
• Scenario B: You're a healthcare or medical device company relying on Bemis's specialized barrier films.
• Scenario C: You're a mid-size consumer goods brand with moderate volume and no existing relationship with either company.

Each scenario demands a different approach. Let me explain.

Scenario A: The High-Volume Food Manufacturer

If you're already buying from Amcor's food packaging division, the Bemis acquisition probably gives you some leverage — but not in the way sales reps will tell you.

Here's what I discovered when I compared quotes in 2023. Vendor A (Amcor) quoted us $0.42 per unit for a standard barrier pouch. Vendor B quoted $0.38. I almost went with B until I calculated the total cost of ownership.

Vendor B charged $75 for setup per SKU, $22 for custom color matching, and shipping added another $0.04 per unit because their facility was farther. Vendor A's $0.42 included setup, standard colors, and regional shipping. The difference? Vendor B's "cheaper" unit price actually cost us $0.46 per unit total — about 9% more.

The merger matters here because Amcor gained Bemis's barrier film technology. For food packaging that requires extended shelf life (think coffee, spices, or meat), Bemis's expertise in oxygen and moisture barriers is now part of Amcor's portfolio. If you need that capability, you have a single-source option that didn't exist before.

My recommendation: Use the merger as leverage to negotiate volume discounts. Amcor wants to retain Bemis's healthcare clients — they'll negotiate on food packaging to keep you. Ask for a 3–5% discount on annual volume commitments. I've seen it work.

Scenario B: The Healthcare or Medical Device Company

This is where it gets tricky. And honestly? A little controversial.

Most healthcare packaging buyers assume the merger means less competition and higher prices. That's the fear, anyway. But my analysis suggests something different.

Bemis's healthcare division — specifically their sharps containers, Tyvek pouches, and sterile barrier films — had a specialized reputation. Amcor's acquisition added these products to a network that spans 130+ plants globally. For a medical device manufacturer, that means access to:

• Broader geographic production (reducing shipping costs)
• Combined R&D for barrier technology
• Streamlined compliance documentation (both companies already met FDA and ISO standards)

But here's the part that surprised me: the merger actually reduced some costs. When I compared quotes for a sterile pouch order (about $4,200 annually for a mid-size client), Amcor's post-merger pricing was 12% lower than Bemis's pre-merger pricing for the same spec. Why? Because Amcor's purchasing power for raw materials is larger, and those savings (theoretically) pass to you.

Note to self: verify this holds for 2025 pricing. Raw material costs have fluctuated.

Scenario C: The Mid-Size Consumer Goods Brand

If you're in this group, you're probably the most vulnerable to price increases — and you might not even realize it.

Why? Because you don't have the volume to command attention, and you don't have the regulatory stickiness to prevent supplier switching. You're in the middle.

I spoke with a colleague at a natural foods brand (about $12M annual revenue) who told me their packaging costs went up 8% in 2024. When I asked if they'd shopped around, they said, "We've been using Bemis for years. We assumed switching now, post-merger, would be complicated."

That's the myth — that the merger makes switching harder. Actually, it makes the market more dynamic. Here's why:

Amcor's acquisition of Bemis means Bemis's capacity is now part of a larger network. But Amcor also needs to keep utilization high across all their facilities. If they lose a mid-size client, they can backfill with another account. For you, that means less leverage — unless you diversify.

The surprise for me: the budget options in this space aren't always worse. When I compared three vendors for a standard stand-up pouch order, the mid-tier option (not Amcor, not a discount printer) actually had the best on-time delivery rate: 94% vs. Amcor's 89%.

My recommendation: Don't assume the merger locks you in. Get quotes from 3 vendors. Use Amcor's scale as a reason to negotiate, not as a reason to stay put.

How to Tell Which Scenario You're In

Here's a quick self-assessment. Answer these three questions:

1. What's your annual packaging spend? Under $50K? You're Scenario C. Over $200K? You're Scenario A or B, depending on your industry.
2. Do you require FDA-compliant or sterile packaging? Yes? Scenario B. No? You could be A or C.
3. How many packaging vendors do you currently use? One? You need to diversify. Three or more? You can afford to consolidate — maybe.

The Bemis-Amcor merger isn't a disaster, and it isn't a windfall. It's a shift in the landscape. The buyers who treat it like a strategic re-assessment — who calculate their TCO, who shop around, who ask better questions — will come out ahead.

The buyers who assume nothing changed? They'll pay for it.